Actively Recruiting

Age: 18Years - 75Years
All Genders
ID05884736

Confirming the Permanent Cessation of Intracranial Circulation During Abdominal Normothermic Regional Perfusion After Death Determination by Circulatory Criteria

Led by Western University, Canada · Updated on 2026-05-19

30

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

Sponsors

W

Western University, Canada

Lead Sponsor

U

University Health Network, Toronto

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the surgical technique used in Abdominal Normothermic Regional Perfusion (A-NRP) for organ donors declared dead by circulatory criteria (DCC). The study aims to confirm that brain blood flow and activity do not resume during the A-NRP procedure by using a multimodal neuromonitoring protocol. This evidence will help ensure donor safety and support the use of A-NRP in standard organ donation practice. The study is a multi-center prospective observational cohort involving eligible DCC donors at participating hospitals. The A-NRP process will be implemented for organ recovery, with neuromonitoring performed by specialized teams independent of the transplant teams. Monitoring includes Transcranial colour-coded Doppler (TCCD) for brain blood flow, Electroencephalography (EEG) for cortical activity, and Somatosensory or brainstem auditory evoked potentials (SSEP or BAEP) for brainstem activity. These measures will be continuously recorded from before life support withdrawal through the A-NRP perfusion process. Participants will have multimodal neuromonitors placed prior to withdrawal of life support, and monitoring data will be collected during withdrawal and A-NRP. Researchers will interpret signals in real-time to detect any evidence of resumed brain blood flow or activity. The primary outcome is to confirm permanent cessation of brain circulation and activity. The study will also track donor accrual and consent rates, neuromonitoring performance, and signal duration over approximately one year of follow-up.

CONDITIONS

Brief Title

Confirming Permanent Lack of Blood Flow to the Brain During A-NRP DCC Organ Transplant

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must be 18 years of age or older
  • Potential donors after circulatory death (DCC) whose families or surrogate decision makers have consented to organ donation
  • Donors may be donating liver, kidneys, pancreas, and/or lungs as per transplant program criteria
Not Eligible

You will not qualify if you...

  • Participants younger than 18 years of age
  • DCC donors who proceed to donation after medical assistance in dying or who can provide first-person consent
  • Donors with injuries that prevent the use of neurological monitoring

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - During withdrawal of life support and A-NRP perfusion process

Participants who are DCC donors undergo multimodal neuromonitoring including Transcranial colour-coded Doppler (TCCD), Electroencephalography (EEG), and Somatosensory or Brainstem Auditory Evoked Potentials during the withdrawal process and A-NRP perfusion to confirm permanent cessation of brain blood flow and activity.

Continuous monitoring during organ donation process

Trial Site Locations

Total: 2 locations

1

London Health Sciences Centre

London, Ontario, Canada, N6A 5A5

Actively Recruiting

2

Toronto Western Hospital

Toronto, Ontario, Canada, M5T 2S8

Not Yet Recruiting

Loading map...

Research Team

C

Crystal Engelage, PhD

A

Anton Skaro, MD PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Exploratory Use of CMV Immunoglobulin in High Risk (D+R-) Tr...

Cytomegalovirus

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here